Birdwatch Note Rating
2023-06-27 14:36:50 UTC - HELPFUL
Rated by Participant: C5806776536F381D415BCFCEF13369BF9CB1AD442E060950A4C22B4C15F61F68
Participant Details
Original Note:
Ketamine, an anesthetic used for many years, was sanctioned by the FDA in 2019 as a nasal spray for individuals suffering from depression that has been resistant to other treatments. Studies have shown it to be as effective as ECT at treating depression. Harvard Health https://www.health.harvard.edu/blog/ketamine-for-treatment-resistant-depression-when-and-where-is-it-safe-202208092797
All Note Details